ALXO
Alx Oncology Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.98
-0.04 ▼ -1.98%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$1.98
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.9 | Insider Own | 47.22% | Shs Outstand | 0.13B | Perf Week | -10.41% |
| Market Cap | 0.26B | Forward P/E | - | EPS next Y | 6.9% | Insider Trans | 5.56% | Shs Float | 0.07B | Perf Month | -20.16% |
| Enterprise Value | 0.23B | PEG | - | EPS next Q | -0.2 | Inst Own | 24.8% | Short Float | 1.69% | Perf Quarter | 28.57% |
| Income | -0.10B | P/S | - | EPS this Y | 61.59% | Inst Trans | 4.2% | Short Ratio | 2.07 | Perf Half Y | 67.8% |
| Sales | 0.00B | P/B | 4.14 | EPS next 5Y | 30.11% | ROA | -98.34% | Short Interest | 1.17M | Perf YTD | 75.22% |
| Book/sh | 0.48 | P/C | 5.82 | EPS past 3/5Y | 14.52% -8.19% | ROE | -145.7% | 52W High | -25.56% ($2.66) | Perf Year | 138.15% |
| Cash/sh | 0.34 | P/FCF | - | Sales past 3/5Y | - | ROIC | -302.01% | 52W Low | 390.1% ($0.40) | Perf 3Y | -64.83% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 27.22% | Gross Margin | - | Volatility(W/M) | 8.69% 10.61% | Perf 5Y | -97.43% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.22 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.07 | EPS Q/Q | 23.79% | Profit Margin | - | RSI (14) | 45.4 | Recom | 1.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.07 | Sales Q/Q | - | SMA20 | -11.29% ($2.23) | Beta | 0.5 | Target Price | $4.5 |
| Payout | - | Debt/Eq | 0.57 | Earnings | 2000000 | SMA50 | 7.26% ($1.85) | Rel Volume | 0.66 | Prev Close | $2.02 |
| Employees | 43 | LT Debt/Eq | 0.3 | EPS/Sales Surpr. | -15.86% - | SMA200 | 55.29% ($1.28) | Avg Volume(3M) | 0.57M | Price | $1.98 |
| IPO | 2020/7/17 | Option/Short | Yes/Yes | Trades | 2342 | Volume | 371,864 | Change | -1.98% |
뉴스 로딩 중...